Jun
2026
Shanghai New International Expo Center
Visit us
stand E16A13, Pharma Ingredients
Yangling JITAI Pharmaceutical CO., LTD
Exhibitor at CPHI & PMEC China 2026
About Us
Categories
-
Country/Region:China
-
On CPHI since:2024
-
Certificates:3
-
Employees:250 - 499
Company types
Primary activities
Event information
CPHI & PMEC China 2026
-
16 Jun 2026 - 18 Jun 2026
-
Shanghai New International Expo Center
-
Visit us at stand E16A13, Pharma Ingredients
Products Featured at CPHI & PMEC China 2026
-
Product Avanafil CAS#330784-47-9; Vildagliptin CAS#274901-16-5
Documentation: DMF, WC,COA Specification: in-house -
Product Dapoxetine Hydrochloride CAS#129938-20-1; Slidenafil Citrate CAS#171599-83-0
For the treatment of prematureejaculation(PE) in men aged 18 to 64 years old. Enterprise standard with a content of 99%. Specification: USP, EP, BP, CHP. Documentation: DMF, WC, COA, GMP. -
Product Oseltamivir Phosphate CAS#204255-11-8
For the treatment and prevention of influenza A and B in adults and children one year and older. Specification: USP, EP, BP, CHP Documentation: DMF, WC, COA, GMP -
Product Tadalafil CAS#171596-29-5
For the treatment of erectile dysfunction. Specification: USP, EP, BP Documentation: DMF, WC, GMP, COA -
Product Vardenafil Hydrochloride CAS# 330808-88-3
For the treatment of penile erectiledys function in men. Specification: USP, EP, BP Documentation: DMF, WC, COA, GMP
Yangling JITAI Pharmaceutical Co.,Ltd Resources (1)
-
Brochure PRODUCT LIST OF PHARMA JITAI
The APIs and intermediates which producing by ourself included in this this product list.




